We are live on ! Find out more
CELUW

Celularity Inc

Delisted

CELUW was delisted on the 17th of July, 2026.

21 hedge funds and large institutions have $9.84M invested in Celularity Inc in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital invested

Capital invested by funds: $6.6M → $9.84M (+$3.24M)

0% more funds holding

Funds holding: 2121 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

Holders
21
Holders Change
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
5
Closed
2
Calls
$2.09M
Puts
Net Calls
+$2.09M
Net Calls Change
+$1.44M

CELUW Hedge Fund Activity: Q1 2022 in Review

21 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q1 2022, worth a combined $9.84M — up 49% from $6.6M a quarter earlier.

Fund positioning in CELUW was balanced in Q1 2022: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 5 trimmed.

The largest buyer was Privium Fund Management, adding an estimated $813K. The largest seller was Linden Advisors, cutting an estimated $1.26M.

  • 21 institutional investors held Celularity Inc (CELUW) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $9.84M of Celularity Inc stock for Q1 2022, up 49% quarter-over-quarter.
  • 2 funds opened new Celularity Inc positions in Q1 2022 and 2 closed out, a net change of 0 holders.
  • The largest Celularity Inc buyer in Q1 2022 was Privium Fund Management, an estimated $813K added.
  • The largest Celularity Inc seller in Q1 2022 was Linden Advisors, an estimated $1.26M sold.

Based on aggregated 13F filings for Q1 2022.